These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16531065)

  • 1. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
    Di Daniel E; Cheng L; Maycox PR; Mudge AW
    Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.
    Di Daniel E; Kew JN; Maycox PR
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1139-43. PubMed ID: 19754467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common mechanism of action for three mood-stabilizing drugs.
    Williams RS; Cheng L; Mudge AW; Harwood AJ
    Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate decreases inositol biosynthesis.
    Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
    Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
    Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH.
    Fu H; Li B; Hertz L; Peng L
    Neurochem Int; 2012 Jul; 61(2):187-94. PubMed ID: 22564531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular cell biology of lithium.
    Williams R; Ryves WJ; Dalton EC; Eickholt B; Shaltiel G; Agam G; Harwood AJ
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):799-802. PubMed ID: 15494019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of mood stabilizer action on neuronal growth cones.
    Shaltiel G; Dalton EC; Belmaker RH; Harwood AJ; Agam G
    Bipolar Disord; 2007 May; 9(3):281-9. PubMed ID: 17430303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can the mood stabilizer VPA limit both mania and depression?
    Cheng L; Lumb M; Polgár L; Mudge AW
    Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG; Watterson JM; Lenox RH
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol synthesis regulates the activation of GSK-3α in neuronal cells.
    Ye C; Greenberg ML
    J Neurochem; 2015 Apr; 133(2):273-83. PubMed ID: 25345501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
    Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
    Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
    Wang JF; Bown C; Young LT
    Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myo-inositol-1-phosphate (MIP) synthase inhibition: in-vivo study in rats.
    Einat H; Tian F; Belmaker RH; Frost JW
    J Neural Transm (Vienna); 2008; 115(1):55-8. PubMed ID: 17828434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?
    Lubrich B; van Calker D
    Neuropsychopharmacology; 1999 Oct; 21(4):519-29. PubMed ID: 10481836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones.
    Uldry M; Steiner P; Zurich MG; Béguin P; Hirling H; Dolci W; Thorens B
    EMBO J; 2004 Feb; 23(3):531-40. PubMed ID: 14749729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
    Cui J; Shao L; Young LT; Wang JF
    Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.